COVID-19 Impact on Global Blood Pressure Disorders Drug Market Size, Status and Forecast 2020-2026

August 2020 | 156 pages | ID: C9DDAC41AFAFEN
QYResearch

Abstracts

This report focuses on the global Blood Pressure Disorders Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Blood Pressure Disorders Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• A1M Pharma AB
• Acceleron Pharma Inc
• Ache Laboratorios Farmaceuticos SA
• Actelion Pharmaceuticals Ltd
• Aerogen Ltd
• Anavex Life Sciences Corp
• AnGes Inc
• Arena Pharmaceuticals Inc
• Ascendia Pharmaceuticals LLC
• Ascendis Pharma A/S
• AVEO Pharmaceuticals Inc
• Bayer AG
• Bial - Portela & Ca SA
• Bioblue Technologies Inc
• Biogen Inc
• Biolab Farmaceutica Ltda
• BioRestorative Therapies Inc
• Boryung Pharmaceutical Co Ltd
• Bristol-Myers Squibb Co
• Camurus AB
• Capricor Therapeutics Inc
• Celsion Corp
• Celtaxsys Inc
• Chiesi Farmaceutici SpA
• Chong Kun Dang Pharmaceutical Corp
• Chugai Pharmaceutical Co Ltd
• CJ HealthCare Corp
• Complexa Inc
• Corion Biotech Srl

Market segment by Type, the product can be split into

• Diuretics
• Angiotensin Converting Enzyme (ACE) Inhibitors
• Angiotensin Receptor Blockers (ARBs)
• Others

Market segment by Application, split into

• Hypertension
• Hypotension
• Pulmonary Hypertension

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Blood Pressure Disorders Drug status, future forecast, growth opportunity, key market and key players.
• To present the Blood Pressure Disorders Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Blood Pressure Disorders Drug are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Blood Pressure Disorders Drug Revenue
1.4 Market Analysis by Type
  1.4.1 Global Blood Pressure Disorders Drug Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Diuretics
  1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
  1.4.4 Angiotensin Receptor Blockers (ARBs)
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Blood Pressure Disorders Drug Market Share by Application: 2020 VS 2026
  1.5.2 Hypertension
  1.5.3 Hypotension
  1.5.4 Pulmonary Hypertension
1.6 Coronavirus Disease 2019 (Covid-19): Blood Pressure Disorders Drug Industry Impact
  1.6.1 How the Covid-19 is Affecting the Blood Pressure Disorders Drug Industry
    1.6.1.1 Blood Pressure Disorders Drug Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Blood Pressure Disorders Drug Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Blood Pressure Disorders Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Blood Pressure Disorders Drug Market Perspective (2015-2026)
2.2 Blood Pressure Disorders Drug Growth Trends by Regions
  2.2.1 Blood Pressure Disorders Drug Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Blood Pressure Disorders Drug Historic Market Share by Regions (2015-2020)
  2.2.3 Blood Pressure Disorders Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Blood Pressure Disorders Drug Market Growth Strategy
  2.3.6 Primary Interviews with Key Blood Pressure Disorders Drug Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Blood Pressure Disorders Drug Players by Market Size
  3.1.1 Global Top Blood Pressure Disorders Drug Players by Revenue (2015-2020)
  3.1.2 Global Blood Pressure Disorders Drug Revenue Market Share by Players (2015-2020)
  3.1.3 Global Blood Pressure Disorders Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Blood Pressure Disorders Drug Market Concentration Ratio
  3.2.1 Global Blood Pressure Disorders Drug Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Blood Pressure Disorders Drug Revenue in 2019
3.3 Blood Pressure Disorders Drug Key Players Head office and Area Served
3.4 Key Players Blood Pressure Disorders Drug Product Solution and Service
3.5 Date of Enter into Blood Pressure Disorders Drug Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Blood Pressure Disorders Drug Historic Market Size by Type (2015-2020)
4.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2021-2026)

5 BLOOD PRESSURE DISORDERS DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Blood Pressure Disorders Drug Market Size by Application (2015-2020)
5.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Blood Pressure Disorders Drug Market Size (2015-2020)
6.2 Blood Pressure Disorders Drug Key Players in North America (2019-2020)
6.3 North America Blood Pressure Disorders Drug Market Size by Type (2015-2020)
6.4 North America Blood Pressure Disorders Drug Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Blood Pressure Disorders Drug Market Size (2015-2020)
7.2 Blood Pressure Disorders Drug Key Players in Europe (2019-2020)
7.3 Europe Blood Pressure Disorders Drug Market Size by Type (2015-2020)
7.4 Europe Blood Pressure Disorders Drug Market Size by Application (2015-2020)

8 CHINA

8.1 China Blood Pressure Disorders Drug Market Size (2015-2020)
8.2 Blood Pressure Disorders Drug Key Players in China (2019-2020)
8.3 China Blood Pressure Disorders Drug Market Size by Type (2015-2020)
8.4 China Blood Pressure Disorders Drug Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Blood Pressure Disorders Drug Market Size (2015-2020)
9.2 Blood Pressure Disorders Drug Key Players in Japan (2019-2020)
9.3 Japan Blood Pressure Disorders Drug Market Size by Type (2015-2020)
9.4 Japan Blood Pressure Disorders Drug Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Blood Pressure Disorders Drug Market Size (2015-2020)
10.2 Blood Pressure Disorders Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Blood Pressure Disorders Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Blood Pressure Disorders Drug Market Size by Application (2015-2020)

11 INDIA

11.1 India Blood Pressure Disorders Drug Market Size (2015-2020)
11.2 Blood Pressure Disorders Drug Key Players in India (2019-2020)
11.3 India Blood Pressure Disorders Drug Market Size by Type (2015-2020)
11.4 India Blood Pressure Disorders Drug Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Blood Pressure Disorders Drug Market Size (2015-2020)
12.2 Blood Pressure Disorders Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Blood Pressure Disorders Drug Market Size by Type (2015-2020)
12.4 Central & South America Blood Pressure Disorders Drug Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 A1M Pharma AB
  13.1.1 A1M Pharma AB Company Details
  13.1.2 A1M Pharma AB Business Overview and Its Total Revenue
  13.1.3 A1M Pharma AB Blood Pressure Disorders Drug Introduction
  13.1.4 A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2015-2020))
  13.1.5 A1M Pharma AB Recent Development
13.2 Acceleron Pharma Inc
  13.2.1 Acceleron Pharma Inc Company Details
  13.2.2 Acceleron Pharma Inc Business Overview and Its Total Revenue
  13.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Introduction
  13.2.4 Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  13.2.5 Acceleron Pharma Inc Recent Development
13.3 Ache Laboratorios Farmaceuticos SA
  13.3.1 Ache Laboratorios Farmaceuticos SA Company Details
  13.3.2 Ache Laboratorios Farmaceuticos SA Business Overview and Its Total Revenue
  13.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Introduction
  13.3.4 Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  13.3.5 Ache Laboratorios Farmaceuticos SA Recent Development
13.4 Actelion Pharmaceuticals Ltd
  13.4.1 Actelion Pharmaceuticals Ltd Company Details
  13.4.2 Actelion Pharmaceuticals Ltd Business Overview and Its Total Revenue
  13.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Introduction
  13.4.4 Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  13.4.5 Actelion Pharmaceuticals Ltd Recent Development
13.5 Aerogen Ltd
  13.5.1 Aerogen Ltd Company Details
  13.5.2 Aerogen Ltd Business Overview and Its Total Revenue
  13.5.3 Aerogen Ltd Blood Pressure Disorders Drug Introduction
  13.5.4 Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  13.5.5 Aerogen Ltd Recent Development
13.6 Anavex Life Sciences Corp
  13.6.1 Anavex Life Sciences Corp Company Details
  13.6.2 Anavex Life Sciences Corp Business Overview and Its Total Revenue
  13.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Introduction
  13.6.4 Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  13.6.5 Anavex Life Sciences Corp Recent Development
13.7 AnGes Inc
  13.7.1 AnGes Inc Company Details
  13.7.2 AnGes Inc Business Overview and Its Total Revenue
  13.7.3 AnGes Inc Blood Pressure Disorders Drug Introduction
  13.7.4 AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  13.7.5 AnGes Inc Recent Development
13.8 Arena Pharmaceuticals Inc
  13.8.1 Arena Pharmaceuticals Inc Company Details
  13.8.2 Arena Pharmaceuticals Inc Business Overview and Its Total Revenue
  13.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
  13.8.4 Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  13.8.5 Arena Pharmaceuticals Inc Recent Development
13.9 Ascendia Pharmaceuticals LLC
  13.9.1 Ascendia Pharmaceuticals LLC Company Details
  13.9.2 Ascendia Pharmaceuticals LLC Business Overview and Its Total Revenue
  13.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Introduction
  13.9.4 Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  13.9.5 Ascendia Pharmaceuticals LLC Recent Development
13.10 Ascendis Pharma A/S
  13.10.1 Ascendis Pharma A/S Company Details
  13.10.2 Ascendis Pharma A/S Business Overview and Its Total Revenue
  13.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Introduction
  13.10.4 Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  13.10.5 Ascendis Pharma A/S Recent Development
13.11 AVEO Pharmaceuticals Inc
  10.11.1 AVEO Pharmaceuticals Inc Company Details
  10.11.2 AVEO Pharmaceuticals Inc Business Overview and Its Total Revenue
  10.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
  10.11.4 AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.11.5 AVEO Pharmaceuticals Inc Recent Development
13.12 Bayer AG
  10.12.1 Bayer AG Company Details
  10.12.2 Bayer AG Business Overview and Its Total Revenue
  10.12.3 Bayer AG Blood Pressure Disorders Drug Introduction
  10.12.4 Bayer AG Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.12.5 Bayer AG Recent Development
13.13 Bial - Portela & Ca SA
  10.13.1 Bial - Portela & Ca SA Company Details
  10.13.2 Bial - Portela & Ca SA Business Overview and Its Total Revenue
  10.13.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Introduction
  10.13.4 Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.13.5 Bial - Portela & Ca SA Recent Development
13.14 Bioblue Technologies Inc
  10.14.1 Bioblue Technologies Inc Company Details
  10.14.2 Bioblue Technologies Inc Business Overview and Its Total Revenue
  10.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Introduction
  10.14.4 Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.14.5 Bioblue Technologies Inc Recent Development
13.15 Biogen Inc
  10.15.1 Biogen Inc Company Details
  10.15.2 Biogen Inc Business Overview and Its Total Revenue
  10.15.3 Biogen Inc Blood Pressure Disorders Drug Introduction
  10.15.4 Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.15.5 Biogen Inc Recent Development
13.16 Biolab Farmaceutica Ltda
  10.16.1 Biolab Farmaceutica Ltda Company Details
  10.16.2 Biolab Farmaceutica Ltda Business Overview and Its Total Revenue
  10.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Introduction
  10.16.4 Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.16.5 Biolab Farmaceutica Ltda Recent Development
13.17 BioRestorative Therapies Inc
  10.17.1 BioRestorative Therapies Inc Company Details
  10.17.2 BioRestorative Therapies Inc Business Overview and Its Total Revenue
  10.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Introduction
  10.17.4 BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.17.5 BioRestorative Therapies Inc Recent Development
13.18 Boryung Pharmaceutical Co Ltd
  10.18.1 Boryung Pharmaceutical Co Ltd Company Details
  10.18.2 Boryung Pharmaceutical Co Ltd Business Overview and Its Total Revenue
  10.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
  10.18.4 Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.18.5 Boryung Pharmaceutical Co Ltd Recent Development
13.19 Bristol-Myers Squibb Co
  10.19.1 Bristol-Myers Squibb Co Company Details
  10.19.2 Bristol-Myers Squibb Co Business Overview and Its Total Revenue
  10.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Introduction
  10.19.4 Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.19.5 Bristol-Myers Squibb Co Recent Development
13.20 Camurus AB
  10.20.1 Camurus AB Company Details
  10.20.2 Camurus AB Business Overview and Its Total Revenue
  10.20.3 Camurus AB Blood Pressure Disorders Drug Introduction
  10.20.4 Camurus AB Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.20.5 Camurus AB Recent Development
13.21 Capricor Therapeutics Inc
  10.21.1 Capricor Therapeutics Inc Company Details
  10.21.2 Capricor Therapeutics Inc Business Overview and Its Total Revenue
  10.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Introduction
  10.21.4 Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.21.5 Capricor Therapeutics Inc Recent Development
13.22 Celsion Corp
  10.22.1 Celsion Corp Company Details
  10.22.2 Celsion Corp Business Overview and Its Total Revenue
  10.22.3 Celsion Corp Blood Pressure Disorders Drug Introduction
  10.22.4 Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.22.5 Celsion Corp Recent Development
13.23 Celtaxsys Inc
  10.23.1 Celtaxsys Inc Company Details
  10.23.2 Celtaxsys Inc Business Overview and Its Total Revenue
  10.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Introduction
  10.23.4 Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.23.5 Celtaxsys Inc Recent Development
13.24 Chiesi Farmaceutici SpA
  10.24.1 Chiesi Farmaceutici SpA Company Details
  10.24.2 Chiesi Farmaceutici SpA Business Overview and Its Total Revenue
  10.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Introduction
  10.24.4 Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.24.5 Chiesi Farmaceutici SpA Recent Development
13.25 Chong Kun Dang Pharmaceutical Corp
  10.25.1 Chong Kun Dang Pharmaceutical Corp Company Details
  10.25.2 Chong Kun Dang Pharmaceutical Corp Business Overview and Its Total Revenue
  10.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Introduction
  10.25.4 Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.25.5 Chong Kun Dang Pharmaceutical Corp Recent Development
13.26 Chugai Pharmaceutical Co Ltd
  10.26.1 Chugai Pharmaceutical Co Ltd Company Details
  10.26.2 Chugai Pharmaceutical Co Ltd Business Overview and Its Total Revenue
  10.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
  10.26.4 Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.26.5 Chugai Pharmaceutical Co Ltd Recent Development
13.27 CJ HealthCare Corp
  10.27.1 CJ HealthCare Corp Company Details
  10.27.2 CJ HealthCare Corp Business Overview and Its Total Revenue
  10.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Introduction
  10.27.4 CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.27.5 CJ HealthCare Corp Recent Development
13.28 Complexa Inc
  10.28.1 Complexa Inc Company Details
  10.28.2 Complexa Inc Business Overview and Its Total Revenue
  10.28.3 Complexa Inc Blood Pressure Disorders Drug Introduction
  10.28.4 Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.28.5 Complexa Inc Recent Development
13.29 Corion Biotech Srl
  10.29.1 Corion Biotech Srl Company Details
  10.29.2 Corion Biotech Srl Business Overview and Its Total Revenue
  10.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Introduction
  10.29.4 Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  10.29.5 Corion Biotech Srl Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Blood Pressure Disorders Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Blood Pressure Disorders Drug Revenue
Table 3. Ranking of Global Top Blood Pressure Disorders Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Blood Pressure Disorders Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diuretics
Table 6. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 7. Key Players of Angiotensin Receptor Blockers (ARBs)
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Blood Pressure Disorders Drug Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Blood Pressure Disorders Drug Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Blood Pressure Disorders Drug Players to Combat Covid-19 Impact
Table 14. Global Blood Pressure Disorders Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Blood Pressure Disorders Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Blood Pressure Disorders Drug Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Blood Pressure Disorders Drug Market Share by Regions (2015-2020)
Table 18. Global Blood Pressure Disorders Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Blood Pressure Disorders Drug Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Blood Pressure Disorders Drug Market Growth Strategy
Table 24. Main Points Interviewed from Key Blood Pressure Disorders Drug Players
Table 25. Global Blood Pressure Disorders Drug Revenue by Players (2015-2020) (Million US$)
Table 26. Global Blood Pressure Disorders Drug Market Share by Players (2015-2020)
Table 27. Global Top Blood Pressure Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Pressure Disorders Drug as of 2019)
Table 28. Global Blood Pressure Disorders Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Blood Pressure Disorders Drug Product Solution and Service
Table 31. Date of Enter into Blood Pressure Disorders Drug Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 34. Global Blood Pressure Disorders Drug Market Size Share by Type (2015-2020)
Table 35. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2021-2026)
Table 36. Global Blood Pressure Disorders Drug Market Size Share by Application (2015-2020)
Table 37. Global Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 38. Global Blood Pressure Disorders Drug Market Size Share by Application (2021-2026)
Table 39. North America Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 41. North America Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 42. North America Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 43. North America Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 44. North America Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 45. Europe Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 47. Europe Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 49. Europe Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 51. China Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 52. China Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 53. China Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 54. China Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 55. China Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 56. China Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 57. Japan Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 59. Japan Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 61. Japan Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 65. Southeast Asia Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 67. Southeast Asia Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 69. India Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 70. India Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 71. India Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 72. India Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 73. India Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 74. India Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 77. Central & South America Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 79. Central & South America Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 81. A1M Pharma AB Company Details
Table 82. A1M Pharma AB Business Overview
Table 83. A1M Pharma AB Product
Table 84. A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 85. A1M Pharma AB Recent Development
Table 86. Acceleron Pharma Inc Company Details
Table 87. Acceleron Pharma Inc Business Overview
Table 88. Acceleron Pharma Inc Product
Table 89. Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 90. Acceleron Pharma Inc Recent Development
Table 91. Ache Laboratorios Farmaceuticos SA Company Details
Table 92. Ache Laboratorios Farmaceuticos SA Business Overview
Table 93. Ache Laboratorios Farmaceuticos SA Product
Table 94. Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 95. Ache Laboratorios Farmaceuticos SA Recent Development
Table 96. Actelion Pharmaceuticals Ltd Company Details
Table 97. Actelion Pharmaceuticals Ltd Business Overview
Table 98. Actelion Pharmaceuticals Ltd Product
Table 99. Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 100. Actelion Pharmaceuticals Ltd Recent Development
Table 101. Aerogen Ltd Company Details
Table 102. Aerogen Ltd Business Overview
Table 103. Aerogen Ltd Product
Table 104. Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 105. Aerogen Ltd Recent Development
Table 106. Anavex Life Sciences Corp Company Details
Table 107. Anavex Life Sciences Corp Business Overview
Table 108. Anavex Life Sciences Corp Product
Table 109. Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 110. Anavex Life Sciences Corp Recent Development
Table 111. AnGes Inc Company Details
Table 112. AnGes Inc Business Overview
Table 113. AnGes Inc Product
Table 114. AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 115. AnGes Inc Recent Development
Table 116. Arena Pharmaceuticals Inc Business Overview
Table 117. Arena Pharmaceuticals Inc Product
Table 118. Arena Pharmaceuticals Inc Company Details
Table 119. Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 120. Arena Pharmaceuticals Inc Recent Development
Table 121. Ascendia Pharmaceuticals LLC Company Details
Table 122. Ascendia Pharmaceuticals LLC Business Overview
Table 123. Ascendia Pharmaceuticals LLC Product
Table 124. Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 125. Ascendia Pharmaceuticals LLC Recent Development
Table 126. Ascendis Pharma A/S Company Details
Table 127. Ascendis Pharma A/S Business Overview
Table 128. Ascendis Pharma A/S Product
Table 129. Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 130. Ascendis Pharma A/S Recent Development
Table 131. AVEO Pharmaceuticals Inc Company Details
Table 132. AVEO Pharmaceuticals Inc Business Overview
Table 133. AVEO Pharmaceuticals Inc Product
Table 134. AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 135. AVEO Pharmaceuticals Inc Recent Development
Table 136. Bayer AG Company Details
Table 137. Bayer AG Business Overview
Table 138. Bayer AG Product
Table 139. Bayer AG Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 140. Bayer AG Recent Development
Table 141. Bial - Portela & Ca SA Company Details
Table 142. Bial - Portela & Ca SA Business Overview
Table 143. Bial - Portela & Ca SA Product
Table 144. Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 145. Bial - Portela & Ca SA Recent Development
Table 146. Bioblue Technologies Inc Company Details
Table 147. Bioblue Technologies Inc Business Overview
Table 148. Bioblue Technologies Inc Product
Table 149. Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 150. Bioblue Technologies Inc Recent Development
Table 151. Biogen Inc Company Details
Table 152. Biogen Inc Business Overview
Table 153. Biogen Inc Product
Table 154. Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 155. Biogen Inc Recent Development
Table 156. Biolab Farmaceutica Ltda Company Details
Table 157. Biolab Farmaceutica Ltda Business Overview
Table 158. Biolab Farmaceutica Ltda Product
Table 159. Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 160. Biolab Farmaceutica Ltda Recent Development
Table 161. BioRestorative Therapies Inc Company Details
Table 162. BioRestorative Therapies Inc Business Overview
Table 163. BioRestorative Therapies Inc Product
Table 164. BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 165. BioRestorative Therapies Inc Recent Development
Table 166. Boryung Pharmaceutical Co Ltd Company Details
Table 167. Boryung Pharmaceutical Co Ltd Business Overview
Table 168. Boryung Pharmaceutical Co Ltd Product
Table 169. Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 170. Boryung Pharmaceutical Co Ltd Recent Development
Table 171. Bristol-Myers Squibb Co Company Details
Table 172. Bristol-Myers Squibb Co Business Overview
Table 173. Bristol-Myers Squibb Co Product
Table 174. Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 175. Bristol-Myers Squibb Co Recent Development
Table 176. Camurus AB Company Details
Table 177. Camurus AB Business Overview
Table 178. Camurus AB Product
Table 179. Camurus AB Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 180. Camurus AB Recent Development
Table 181. Capricor Therapeutics Inc Company Details
Table 182. Capricor Therapeutics Inc Business Overview
Table 183. Capricor Therapeutics Inc Product
Table 184. Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 185. Capricor Therapeutics Inc Recent Development
Table 186. Celsion Corp Company Details
Table 187. Celsion Corp Business Overview
Table 188. Celsion Corp Product
Table 189. Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 190. Celsion Corp Recent Development
Table 191. Celtaxsys Inc Company Details
Table 192. Celtaxsys Inc Business Overview
Table 193. Celtaxsys Inc Product
Table 194. Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 195. Celtaxsys Inc Recent Development
Table 196. Chiesi Farmaceutici SpA Company Details
Table 197. Chiesi Farmaceutici SpA Business Overview
Table 198. Chiesi Farmaceutici SpA Product
Table 199. Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 200. Chiesi Farmaceutici SpA Recent Development
Table 201. Chong Kun Dang Pharmaceutical Corp Company Details
Table 202. Chong Kun Dang Pharmaceutical Corp Business Overview
Table 203. Chong Kun Dang Pharmaceutical Corp Product
Table 204. Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 205. Chong Kun Dang Pharmaceutical Corp Recent Development
Table 206. Chugai Pharmaceutical Co Ltd Company Details
Table 207. Chugai Pharmaceutical Co Ltd Business Overview
Table 208. Chugai Pharmaceutical Co Ltd Product
Table 209. Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 210. Chugai Pharmaceutical Co Ltd Recent Development
Table 211. CJ HealthCare Corp Company Details
Table 212. CJ HealthCare Corp Business Overview
Table 213. CJ HealthCare Corp Product
Table 214. CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 215. CJ HealthCare Corp Recent Development
Table 216. Complexa Inc Company Details
Table 217. Complexa Inc Business Overview
Table 218. Complexa Inc Product
Table 219. Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 220. Complexa Inc Recent Development
Table 221. Corion Biotech Srl Company Details
Table 222. Corion Biotech Srl Business Overview
Table 223. Corion Biotech Srl Product
Table 224. Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 225. Corion Biotech Srl Recent Development
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Blood Pressure Disorders Drug Market Share by Type: 2020 VS 2026
Figure 2. Diuretics Features
Figure 3. Angiotensin Converting Enzyme (ACE) Inhibitors Features
Figure 4. Angiotensin Receptor Blockers (ARBs) Features
Figure 5. Others Features
Figure 6. Global Blood Pressure Disorders Drug Market Share by Application: 2020 VS 2026
Figure 7. Hypertension Case Studies
Figure 8. Hypotension Case Studies
Figure 9. Pulmonary Hypertension Case Studies
Figure 10. Blood Pressure Disorders Drug Report Years Considered
Figure 11. Global Blood Pressure Disorders Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Blood Pressure Disorders Drug Market Share by Regions: 2020 VS 2026
Figure 13. Global Blood Pressure Disorders Drug Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Blood Pressure Disorders Drug Market Share by Players in 2019
Figure 16. Global Top Blood Pressure Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Pressure Disorders Drug as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Blood Pressure Disorders Drug Revenue in 2019
Figure 18. North America Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. A1M Pharma AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. A1M Pharma AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 27. Acceleron Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Acceleron Pharma Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 29. Ache Laboratorios Farmaceuticos SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Ache Laboratorios Farmaceuticos SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 31. Actelion Pharmaceuticals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Actelion Pharmaceuticals Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 33. Aerogen Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Aerogen Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 35. Anavex Life Sciences Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Anavex Life Sciences Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 37. AnGes Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. AnGes Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 39. Arena Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Arena Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 41. Ascendia Pharmaceuticals LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Ascendia Pharmaceuticals LLC Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 43. Ascendis Pharma A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Ascendis Pharma A/S Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 45. AVEO Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. AVEO Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 47. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Bayer AG Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 49. Bial - Portela & Ca SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bial - Portela & Ca SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 51. Bioblue Technologies Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bioblue Technologies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 53. Biogen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Biogen Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 55. Biolab Farmaceutica Ltda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Biolab Farmaceutica Ltda Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 57. BioRestorative Therapies Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. BioRestorative Therapies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 59. Boryung Pharmaceutical Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Boryung Pharmaceutical Co Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 61. Bristol-Myers Squibb Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Bristol-Myers Squibb Co Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 63. Camurus AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Camurus AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed